About Orca Bio
Transforming allogeneic cell therapy for patients with cancer and autoimmune diseases.
- Industry
- Pharmaceutical Manufacturing
- Company size
- 201-500 employees
- Headquarters
- Menlo Park, CA
- Founded
- 2016
- Company type
- Privately Held
Orca Bio is a late-stage biotechnology company developing high-precision cell therapies for the treatment of blood cancer and autoimmune diseases. Our investigational products are designed to replace a patient’s diseased blood and immune system with a healthy one. Our manufacturing platform uses single-cell precision to create proprietary, uniquely-defined products that have the potential to revolutionize allogeneic cell therapy.
Our team of leading scientists, engineers and clinicians is united in our mission to transform the lives of patients. Together, we are working to deliver the promise of a cure, without the compromise.
Please note, a member of the Orca Bio team will only ever communicate using an @orcabio.com email address.
Company locations
3475 Edison Way, Suite B, Menlo Park, CA 94025, US
3400 Business Dr, 140, Sacramento, California 95820, US
Locations listed on the company profile. These may include offices outside the United States, and not every location is hiring.
On LinkedIn
- Followers
- 23,510
- People linked to this company
- 327
People who list this company on LinkedIn, not a verified employee count. Figures reflect the saved company profile.
Explore the company
Employer category
Other employer
Estimated from the company profile. This category has not been confirmed by the employer.